Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-12-3
pubmed:abstractText
We recently reported that interleukin-18 (IL-18) is highly expressed in malignant skin tumours such as melanomas, and may play a key role in the malignancy of such tumours. This study was designed to investigate the mechanisms of IL-18 regulation by vitamin C in B16F10 murine melanoma cells. Cells were treated with vitamin C, and the expression of IL-18 was measured by reverse transcription-polymerase chain reaction and intracellular flow cytometry analysis. Decreased IL-18 production and a significant reduction in IL-18 mRNA transcript were detected in cells treated with vitamin C. The effect of vitamin C treatment was blocked by the antioxidant N-acetyl-L-cysteine, suggesting that vitamin C affects IL-18 expression by up-regulating intracellular reactive oxygen intermediate (ROI) levels. To investigate whether the mitogen-activated protein kinase (MAPK) signalling pathway is involved in the downregulation of IL-18 production, cells were pretreated with SB203580, an inhibitor of p38 MAPK, prior to the addition of vitamin C. This pretreatment blocked the decrease in IL-18 production. However, vitamin C treatment enhanced the expression of phosphorylated p38 MAPK. Taken together, we conclude that vitamin C increases intracellular ROI levels, and regulates IL-18 production through the MAPK signalling pathway.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0960-8931
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
549-54
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:14646616-Acetylcysteine, pubmed-meshheading:14646616-Animals, pubmed-meshheading:14646616-Antioxidants, pubmed-meshheading:14646616-Ascorbic Acid, pubmed-meshheading:14646616-Blotting, Western, pubmed-meshheading:14646616-Cell Line, Tumor, pubmed-meshheading:14646616-Densitometry, pubmed-meshheading:14646616-Down-Regulation, pubmed-meshheading:14646616-Enzyme Inhibitors, pubmed-meshheading:14646616-Flow Cytometry, pubmed-meshheading:14646616-Imidazoles, pubmed-meshheading:14646616-Immunoprecipitation, pubmed-meshheading:14646616-Interleukin-18, pubmed-meshheading:14646616-MAP Kinase Signaling System, pubmed-meshheading:14646616-Melanoma, pubmed-meshheading:14646616-Mice, pubmed-meshheading:14646616-Pyridines, pubmed-meshheading:14646616-RNA, Messenger, pubmed-meshheading:14646616-Reactive Oxygen Species, pubmed-meshheading:14646616-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:14646616-Signal Transduction, pubmed-meshheading:14646616-Skin Neoplasms, pubmed-meshheading:14646616-Time Factors, pubmed-meshheading:14646616-p38 Mitogen-Activated Protein Kinases
pubmed:year
2003
pubmed:articleTitle
Vitamin C downregulates interleukin-18 production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signalling in B16F10 murine melanoma cells.
pubmed:affiliation
Department of Life Science, Sookmyung Women's University, Seoul, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't